Fig. 1

Kaplan–Meier method estimated 28-days mortality in patients with myocardial infarction stratified by midazolam (A), dexmedetomidine (B) or propofol (C). Patients with more than one seditive using were not included in Kaplan–Meier analysis
Kaplan–Meier method estimated 28-days mortality in patients with myocardial infarction stratified by midazolam (A), dexmedetomidine (B) or propofol (C). Patients with more than one seditive using were not included in Kaplan–Meier analysis